![Scott Gangloff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Scott A. Gangloff worked at Incyte Corp.
from 2017 to 2024 as VP-Global Biopharmaceutical Development.
Mr. Gangloff worked at Akero Therapeutics, Inc. from 2024 to 2025 as Chief Technical Officer.
Mr. Gangloff graduated from Lehigh University.
Former positions of Scott Gangloff
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09/12/2025 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/04/2024 |
Training of Scott Gangloff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Scott Gangloff
